Full Press Release Details
Immutep to Participate at the Jefferies Healthcare Conference.
IMMP
Immutep to Participate at the Jefferies Healthcare Conference
Key Takeaway: Immutep to Participate at the Jefferies Healthcare Conference
Price reaction · baseline $2.18 (2023-06-06 close) · hit after-hours · clean, no other IMMP news in the window
day 0 close
-0.5%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+76%
120-day peak, hindsight
Typical move
5.4%
average across 13 past catalysts
Lead asset
eftilagimod alfa
Phase 3 · Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)